Antiproliferative agent-54
Antiproliferative agent-54 (Compound 6z) is the inhibitor for multiple kinases, such as ABL WT, B-RAF, EGFR, HCK, LYN A and SRC with IC50 of 6-50 nM. Antiproliferative agent-54 inhibits proliferation of several cancer cell, inhibits HUVEC and HepG2, with EC50 of 34 and 38 nM. Antiproliferative agent-54 exhibits good pharmacokinetic characteristics in rats.
For research use only. We do not sell to patients.
- CAS No.: 1240322-54-6
- Formula: C29H25F3N6O3
- Molecular Weight:562.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IC50: 6 nM (ABL WT); 10 nM (B-RAFV600E); 15 nM (EGFR WT); 22 nM (HCK); 37 nM (LYN A); 40 nM (c-SRC); 44 nM (YES); 46 nM (ABLG250E); 50 nM (PDGFRA)
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | EC50 |
64 nM
Compound: 6z
|
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| BaF3 | EC50 |
0.04 nM
Compound: 6z
|
Inhibition of human wild type BCR-ABL expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Inhibition of human wild type BCR-ABL expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 27010810] |
| BaF3 | EC50 |
1.8 nM
Compound: 6z
|
Inhibition of human BCR-ABL T315I mutant expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
Inhibition of human BCR-ABL T315I mutant expressed in mouse BAF3 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay
|
[PMID: 27010810] |
| BXPC-3 | EC50 |
35 nM
Compound: 6z
|
Antiproliferative activity against human BxPC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human BxPC3 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| CAKI-2 | EC50 |
22 nM
Compound: 6z
|
Antiproliferative activity against human Caki2 cells after 72 hrs by MTT assay
Antiproliferative activity against human Caki2 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| HepG2 | EC50 |
38 nM
Compound: 6z
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| HT-29 | EC50 |
37 nM
Compound: 6z
|
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| HUVEC | EC50 |
34 nM
Compound: 6z
|
Antiangiogenic activity in HUVEC after 72 hrs by MTT assay
Antiangiogenic activity in HUVEC after 72 hrs by MTT assay
|
[PMID: 27010810] |
| MDA-MB-231 | EC50 |
158 nM
Compound: 6z
|
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
| NCI-H1975 | EC50 |
104 nM
Compound: 6z
|
Antiproliferative activity against human NCI-H1975 cells harboring EGFR L858R/T790M double mutant after 72 hrs by MTT assay
Antiproliferative activity against human NCI-H1975 cells harboring EGFR L858R/T790M double mutant after 72 hrs by MTT assay
|
[PMID: 27010810] |
| PBMC | EC50 |
1.2 μM
Compound: 6z
|
Hematotoxicity in human PHA/IL2-stimulated PBMC
Hematotoxicity in human PHA/IL2-stimulated PBMC
|
[PMID: 27010810] |
| PC-3 | EC50 |
152 nM
Compound: 6z
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 27010810] |
Chemical Information
-
CAS No. 1240322-54-6
-
Molecular Weight 562.54
-
Formula C29H25F3N6O3
-
SMILES
O=C(C1=CC2=CC(NCC3=CC(NC(C4=CC(C(F)(F)F)=CC(N5C=C(C)N=C5)=C4)=O)=CC=C3C)=CN=C2N1)OC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)